Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43
View abstract on PubMed
Summary
This summary is machine-generated.Frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) involves amyloid fibrils. These fibrils are unexpectedly formed by transmembrane protein 106B (TMEM106B), not TDP-43 itself.
Area Of Science
- Neurodegenerative diseases
- Molecular biology
- Protein biochemistry
Background
- Frontotemporal lobar degeneration (FTLD) is a common neurodegenerative disorder.
- FTLD-TDP is a subtype characterized by TAR DNA-binding protein (TDP-43) inclusions.
- TMEM106B is a known genetic risk factor for FTLD-TDP.
Purpose Of The Study
- To determine the composition of amyloid fibrils in FTLD-TDP.
- To investigate the structural basis of FTLD-TDP pathology.
Main Methods
- Cryo-electron microscopy to determine fibril structures.
- Amyloid fibril extraction from patient brain samples.
- Immunogold labeling to detect aggregated proteins.
Main Results
- Amyloid fibrils were extracted from four FTLD-TDP patient brains.
- All examined fibrils were composed of TMEM106B, not TDP-43.
- Abundant non-fibrillar aggregated TDP-43 was also detected.
Conclusions
- FTLD-TDP pathology involves amyloid fibrils.
- These fibrils are formed by TMEM106B, challenging previous assumptions.
- TMEM106B aggregation is central to FTLD-TDP pathogenesis.

